医学
药品审批
梅德林
肿瘤科
重症监护医学
内科学
药理学
政治学
法学
药品
作者
Lola A. Fashoyin-Aje,Gautam U. Mehta,Julia A. Beaver,Richard Pazdur
摘要
To address ongoing concerns about the implementation of the FDA's Accelerated Approval pathway in oncology, a comprehensive strategy is needed — one that equally emphasizes "on-ramp" and "off-ramp" considerations.
科研通智能强力驱动
Strongly Powered by AbleSci AI